 COURSE M3: Patients receive vincristine IV on day 0; cyclophosphamide IV over 30 minutes on days 0 and 1; PRED or MePRDL IV or orally twice daily on days 0-7; and doxorubicin IV over 30-60 minutes on day 0 after first dose of cyclophosphamide. 